21Shares Injective ETF filing advances with amended S-1

An amended S-1 registration statement has been filed for the 21Shares Injective ETF tied to $INJ.
The filing represents another step in the regulatory process for bringing direct Injective investment exposure into an ETF structure.
The filing itself does not constitute SEC approval, but continued progress could expand institutional and brokerage access to $INJ if the product ultimately receives authorization and launches.